Key facts
- This page summarizes Scott Centea's Form 4/A - Amendment filing for ANGIODYNAMICS INC (ANGO).
- 3 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 21 Sep 2023, 21:17.
Scott Centea - 19 Jul 2023 Form 4/A - Amendment Insider Report for ANGIODYNAMICS INC (ANGO)
- Reporting relationship
- SVP/GM, VIT
- Issuer ticker
- ANGO
- Reported as of
- 19 Jul 2023
- Net transaction value
- -$24,227
- SEC form
- 4/A - Amendment
- Accepted by SEC
- 21 Sep 2023, 21:17:23 UTC
- Original report date
- 26 Jul 2023
- Prior SEC filing
- 18 Jul 2023
- Next SEC filing
- 25 Jul 2023
- Source filing
- View source filing
- Reporting owner signature
- /s/ Stephen A. Trowbridge, Attorney in Fact
Source evidence
Original filing metadata and source links for verification.
6 source fields
Reporting owner
1 detail
Key filing fact
Scott Centea filed Form 4/A - Amendment for ANGIODYNAMICS INC (ANGO) on 21 Sep 2023.
Change
- Previous filing in this sequence was filed on 18 Jul 2023.
- Current net transaction value: -$24,227.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4/A - Amendment disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
ANGO
transaction
Common Stock
Options Exercise
- Transaction value
- $0
- Shares
- +7,539
- Change %
- +13%
- Price
- $0.000000
- Shares after
- 65,667
- Date
- 19 Jul 2023
- Ownership
- Direct
- Footnotes
- F1
ANGO
transaction
Common Stock
Tax liability
- Transaction value
- $24,227
- Shares
- -2,716
- Change %
- -4.1%
- Price
- $8.92
- Shares after
- 62,951
- Date
- 19 Jul 2023
- Ownership
- Direct
- Footnotes
- F2
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
ANGO
transaction
Derivative
Performance Right
Options Exercise
- Transaction value
- $0
- Shares
- -11,782
- Change %
- -100%
- Price
- $0.000000*
- Shares after
- 0
- Date
- 19 Jul 2023
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 11,782
- Exercise price
- Footnotes
- F3
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 3 footnotes
Footnote F1
This acquisition of 7,539 shares of Common Stock ("Common Stock") of AngioDynamics, Inc. ("AngioDynamics") represents shares acquired through the vesting and settlement of performance share units granted to the reporting person on July 14, 2020.
Footnote F2
The exempt disposition of 2,716 shares of Common Stock of AngioDynamics was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying performance share units granted to the reporting person on July 14, 2020.
Footnote F3
On July 14, 2020, the reporting person received a target grant of 11,782 performance share units. Between 0% and 200% of the target number was to be earned based on achievement of pre-determined performance metrics for fiscal years 2021, 2022 and 2023. In addition, 20% of the total shares earned could be awarded (or cancelled) based on total shareholder return relative to a peer group of companies over a three-year performance period in accordance with performance metrics as determined by the compensation committee. Based on performance over the period, 7,539 shares of Common Stock were issued to the reporting person under this grant and the remaining shares were forfeited.
SEC remarks
This Form 4/A is being filed to correct the number of shares received by the Reporting Person and subsequently sold to satisfy tax withholding obligations in connection with the vesting and settlement of performance share units on 07/19/2023 and provides corrected amounts in Columns 4 and 5 of Table I.